Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. - Wikidata - awgldk - TriplyDB

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

http://www.wikidata.org/entity/Q41847599

about

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines Bone Regeneration from PLGA Micro-Nanoparticles Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes Nanotechnology applications in urology: a review Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancer Targeted therapy using nanotechnology: focus on cancer Mesoscale nanoparticles selectively target the renal proximal tubule epithelium Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis Polymeric nanoparticles for targeted treatment in oncology: current insights Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro A Facile Approach to Functionalize Cell Membrane-Coated Nanoparticles Protease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Extracellularly activatable nanocarriers for drug delivery to tumors.Biomedical Applications of Biodegradable Polymers.Boron polylactide nanoparticles exhibiting fluorescence and phosphorescence in aqueous medium.Current advances in research and clinical applications of PLGA-based nanotechnology.Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.Ultra-high throughput synthesis of nanoparticles with homogeneous size distribution using a coaxial turbulent jet mixer Intravenously administered nanoparticles increase survival following blast trauma.Polymeric nanoparticles for pulmonary protein and DNA delivery.Anticancer drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatment Controlled synthesis of camptothecin-polylactide conjugates and nanoconjugates Enhanced MRI T 2 Relaxivity in Contrast-Probed Anchor-Free PEGylated Iron Oxide Nanoparticles.Poly(ethylene glycol) with observable shedding Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord.Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery Aptamer-targeted cell-specific RNA interference Investigation of endocytosis and cytotoxicity of poly-d, l-lactide-poly(ethylene glycol) micro/nano-particles in osteoblast cells.Optical imaging-guided cancer therapy with fluorescent nanoparticles Formulation/preparation of functionalized nanoparticles for in vivo targeted drug delivery.The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Self-assembled lipid nanomedicines for siRNA tumor targeting.A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.

P2860

Q24596232-F5AA6ED4-2510-469B-8778-003B04467DC0 Q26745586-238A9276-B284-4736-A0E6-016E84E377AF Q26773073-A9FE8074-8264-4162-841C-C280CA7F8054 Q26778233-A1BA17DD-011E-4613-921F-66A0C1587E99 Q26830537-49FEA6BD-2EBB-484D-B2F8-29A410B22CD6 Q27009446-B480D5D2-3E4C-4143-BF7D-83B6ECC820F4 Q27015050-C19EB1F9-B144-4AE3-A874-B2A9A1FE9572 Q27022134-AA5725EA-B212-4859-990D-4404C53512BC Q27023361-77953F6F-AE69-417C-8B08-AFDE81F3AA30 Q27335127-D331459F-8416-4D77-90E3-4E88F32D23D3 Q28086953-B0AA6793-AF0C-46D5-A26E-E5E26150157A Q28087243-1814A1AE-158B-4146-B259-BEF4FC37B1D5 Q28476756-5113B1D6-45C8-4A47-BC79-D9D3EDEEBC14 Q28833663-E3433EAA-B071-4435-B762-9E73A53DF323 Q30355600-09111A03-F960-4EDB-B198-DB121C5080B9 Q30401826-FC03C543-9B63-4E51-AA8E-BE9172391A70 Q30426452-2A544F6B-C5AE-45A4-869D-E5BA113EEE09 Q30440645-4F98EA92-8B00-4996-A12B-38E72985709A Q30482916-11FF0C41-8EDD-4D2D-825D-5D8C201DB74F Q30501637-39CFCFD9-AD98-4D1C-88A9-176F638F4C77 Q30524254-AB9958F5-7CBD-40E5-B129-906F64F004F9 Q30581724-CDC23502-2516-4670-8D72-BECFCE4B23C2 Q30584438-9C5658D1-5E37-41ED-B790-CF649B80A6EA Q33560960-07428453-C3AD-4F63-9BA5-820CCB409F0D Q33593987-C1CCFF43-8848-4546-8FD4-121B70CDB029 Q33601744-DD66DB20-FAFB-4DFC-B446-E1B47FEE0799 Q33609943-35D15A40-85F3-4D6F-832B-A41A310FDCF9 Q33647205-99A3E613-F586-420B-AFBC-542D19B5BC40 Q33653678-E7CE476E-1D24-4BD5-BF77-510A2A106B2F Q33695863-5C31ECB7-1EE4-484B-9579-74BFA2EF81DD Q33717239-BB4D412E-CE52-42C3-B4EC-7B2183691CB8 Q33721938-19276293-475C-4564-BDCD-BD6432064838 Q33731037-5442A06C-4141-492F-9CFD-6865B1EE4862 Q33760895-4342711B-3232-4BA4-ABE7-B9CBE815B2DF Q33772783-6B34831C-ABEF-4C4C-A8E4-A71ECD437C93 Q33834772-28B250DD-34AD-4875-B211-6F19B5495152 Q33893647-CDD130EF-2C1D-4A67-80F9-BAB117C863D5 Q33902253-74AECE08-9DDC-46CE-94D5-8878B4DAEC34 Q33907953-31164833-46E6-4DE6-8570-AFDBB733EAA0 Q33949801-D5E8D4B6-3FB6-419D-A65F-EAC0EE304B75

P2860

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

http://www.wikidata.org/entity/Q41847599

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

@en

type

label

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

@en

prefLabel

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

@en

P1433

Q41847599-CE84353A-17AD-4045-8B43-F4576038214A

P1476

Q41847599-31CD6C8B-CF0C-4DB9-95BB-01D879FBB251

P2093

Q41847599-14DB3C6E-58C1-4CC8-8BCF-E72612E841DD

Q41847599-3001DBC9-6768-47A9-B51B-33906620C6D3

Q41847599-55DB1A02-18BD-47FF-95E4-140FFA071DB2

Q41847599-7F40459F-A94D-4B34-B154-5DCCFCD96482

Q41847599-832FB910-BAEF-4931-A5BE-79E4831D1822

Q41847599-90A8F596-184C-4836-9C6E-40300A88752C

Q41847599-AABE0F8E-8B54-45DC-9610-422AC7354B43

Q41847599-DB6EB36F-4FD4-41F1-A93F-4AA22B1524F2

Q41847599-F7618896-12DD-4A1B-A270-EBE6DA6B0F5B

P2860

Q41847599-0151A495-0ED7-43A3-9ADB-462BDFACC83B

Q41847599-0F13C35E-5D6D-4CFD-9B51-A394B05634C8

Q41847599-3AAF2D93-AE19-4505-91A0-0ADFCA4DF09B

Q41847599-4AC0A94C-266A-414A-BF0B-2B0DF1A8EF86

Q41847599-4BE09812-40C5-49D7-99E5-2D74374C516B

Q41847599-511E853E-6675-44B1-90A6-2FC556F378A9

Q41847599-6244F8C4-8746-4BA7-B8A8-5BC78A30E4BE

Q41847599-69D73E1C-3DA8-4E04-A2E7-7E068CFAF640

Q41847599-94885050-0468-45E0-A454-5D27847BEC29

Q41847599-A6612B67-C1AF-4757-8FB3-83DA65A8843B

P304

Q41847599-942C68C7-4692-4F00-8A54-DCC6A2AB564B

P31

Q41847599-7D1F2776-43EB-4538-9004-BD6A70A7D039

P356

Q41847599-84A25771-98BE-4A27-99F1-33417374F8C6

P433

Q41847599-7BEE363D-D15E-4571-B8C3-B7C6ADC7936C

P478

Q41847599-36DD4BE8-F250-473D-A2CF-C94ED95134BF

P50

Q41847599-69C22F80-D9D1-4D87-AA52-4BECC9AA19E0

P577

Q41847599-A98D4280-DC5F-4DA5-AF02-6F4AAFD3B1BA

P5875

Q41847599-058C73AC-E680-497E-A9BA-A3F9D503F93A

P698

Q41847599-01DF5265-B271-4609-99D0-05AB5ADF75DA

P921

Q41847599-7E356672-8126-45C4-8AD5-DEABD6F53B68

Q41847599-ECDE9272-F24C-42B7-85D0-BBCED60DF3FC

P932

Q41847599-2C95B6FC-A385-41F9-A3AD-46B49D1C61E1

P356

J.BIOMATERIALS.2006.09.047

P1433

P1476

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

@en

P2093

Aleksandar F Radovic-Moreno

http://www.w3.org/2001/XMLSchema#string

Benjamin A Teply

http://www.w3.org/2001/XMLSchema#string

Etgar Levy-Nissenbaum

http://www.w3.org/2001/XMLSchema#string

Frank X Gu

http://www.w3.org/2001/XMLSchema#string

Gaurav Luther

http://www.w3.org/2001/XMLSchema#string

Ines Sherifi

http://www.w3.org/2001/XMLSchema#string

Jianjun Cheng

http://www.w3.org/2001/XMLSchema#string

Josephine Sung

http://www.w3.org/2001/XMLSchema#string

Robert Langer

http://www.w3.org/2001/XMLSchema#string

P2860

Small-scale systems for in vivo drug delivery

Drug delivery systems: entering the mainstream

Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs.

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

Nanoparticles in cancer therapy and diagnosis.

Nanoparticle and targeted systems for cancer therapy.

The changing face of prostate cancer.

Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.

P304

869-876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2006.09.047

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Omid C. Farokhzad

P577

2006-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6739519

http://www.w3.org/2001/XMLSchema#string

P698

17055572

http://www.w3.org/2001/XMLSchema#string

P921

P932

2925222

http://www.w3.org/2001/XMLSchema#string